ATC Group: L01XA02 Carboplatin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01XA02 in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01X Other antineoplastic agents
4 L01XA Platinum compounds
5 L01XA02 Carboplatin

Active ingredients in L01XA02

Active Ingredient Description
Carboplatin

Carboplatin interferes with DNA intrastrand and interstrand crosslinks in cells exposed to the drug. DNA reactivity has been correlated with cytotoxicity.

Related product monographs

Title Information Source Document Type  
KEMOCARB Concentrate for solution for infusion Health Sciences Authority (SG) MPI, Generic

Medicines in this ATC group

United States (US)

Ecuador (EC)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Singapore (SG)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.